Investigating the role of PDEF in prostate cancer disparities among African American men
Prostate Cancer Health Disparity: Role of PDEF
This study is looking into why prostate cancer tends to be more aggressive in African American men than in Caucasian men, focusing on how two proteins, PDEF and TWIST-1, might play a role in this difference, with the hope of improving treatment options and understanding for everyone affected by prostate cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10926853 on NIH RePORTER |
What this research studies
This research focuses on understanding why prostate cancer is more aggressive in African American men compared to Caucasian men. It examines the role of a protein called PDEF (Prostate Derived Ets Factor) and its relationship with another protein, TWIST-1, in influencing cancer behavior. The study involves analyzing prostate cancer cells and tissues to see how PDEF levels change with cancer aggressiveness and how these changes might affect patient outcomes. By identifying these molecular markers, the research aims to improve the understanding of prostate cancer disparities and potentially guide treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American men diagnosed with prostate cancer, particularly those with aggressive forms of the disease.
Not a fit: Patients who are not African American or those with indolent prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatment strategies for prostate cancer in African American men.
How similar studies have performed: Previous research has indicated that examining molecular markers like PDEF can provide insights into cancer behavior, suggesting that this approach has potential for success.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Koul, Hari K — Lsu Health Sciences Center
- Study coordinator: Koul, Hari K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.